Cargando…
Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus
BACKGROUND: Gastrointestinal (GI) symptoms are common in patients with type 2 diabetes mellitus (T2DM). Rebamipide is an effective gastric cytoprotective agent, but there are few data on its usefulness in T2DM. The aim of this study is to evaluate the improvement of GI symptoms after rebamipide trea...
Autores principales: | Park, Sejeong, Park, So Young, Kim, Yu Jin, Hong, Soo Min, Chon, Suk, Oh, Seungjoon, Woo, Jeong-taek, Kim, Sung-Woon, Kim, Young Seol, Rhee, Sang Youl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929228/ https://www.ncbi.nlm.nih.gov/pubmed/27098506 http://dx.doi.org/10.4093/dmj.2016.40.3.240 |
Ejemplares similares
-
Response: Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:240-7)
por: Park, Sejeong, et al.
Publicado: (2016) -
Cardio-Ankle Vascular Index as a Surrogate Marker of Early Atherosclerotic Cardiovascular Disease in Koreans with Type 2 Diabetes Mellitus
por: Park, So Young, et al.
Publicado: (2018) -
Hemoglobin A1c May Be an Inadequate Diagnostic Tool for Diabetes Mellitus in Anemic Subjects
por: Son, Jung Il, et al.
Publicado: (2013) -
A Smartphone Application Significantly Improved Diabetes Self-Care Activities with High User Satisfaction
por: Kim, Yu Jin, et al.
Publicado: (2015) -
Clinical Experience of an Iontophoresis Based Glucose Measuring System
por: Rhee, Sang Youl, et al.
Publicado: (2007)